BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, May 8, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 27, 2001
View Archived Issues
Lexicon Genetics reaches milestone in drug development alliance with Bristol-Myers Squibb
Read More
Phase II clinical data for secretin presented at Autism Society meeting
Read More
Elan licenses European rights to DepoCyte from SkyePharma
Read More
Thalomid to be submitted for new indication this year
Read More
Two recent clinical studies do not support the use of dopamine D1/5 antagonists in cocaine abuse
Read More
Randomized trial shows that cranberry juice prevents recurrence of UTI
Read More
Safety and efficacy of finasteride similar in younger and older men
Read More
Proton pump inhibitors provide the best heartburn relief
Read More
Medarex enters antibody collaboration with Human Genome Sciences
Read More
Prana Biotechnology awarded a START grant for AD drug development
Read More
OxyContin labeling changes reflect new FDA warnings
Read More
ViaCell acquires Cerebrotec
Read More
Feasibility of s.c. vaccination with VAQTA demonstrated
Read More
Head-to-head osteoporosis fracture study comparing Evista and Fosamax
Read More
Immediate pain following i.m. injection of QS-21 may be alleviated with certain excipients
Read More
Stand-alone package of Rebetol approved in U.S.
Read More
FDA advisory committee does not recommend approval of Symlin
Read More
MedImmune begins additional study of siplizumab in psoriasis patients
Read More
Two new Zonagen erectile dysfunction products evaluated in phase II trials
Read More
CancerVax to seek marketing approval of Canvaxin melanoma vaccine in Canada
Read More
New anticoagulants particularly suited for thrombosis and heparin-associated thrombocytopenia
Read More
Agouron's new rotamase-inhibitory neurotrophic agents
Read More
New adenosine derivatives with cardiac effects reported by CV Therapeutics
Read More
Selective JNK modulators and their use described by ARS
Read More
Abbott patents new series of peptide angiogenesis inhibitors
Read More